Literature DB >> 21036249

Measuring the constitutive activation of c-Jun N-terminal kinase isoforms.

Ryan T Nitta1, Shawn S Badal, Albert J Wong.   

Abstract

The c-Jun N-terminal kinases (JNK) are important regulators of cell growth, proliferation, and apoptosis. JNKs are typically activated by a sequence of events that include phosphorylation of its T-P-Y motif by an upstream kinase, followed by homodimerization and translocation to the nucleus. Constitutive activation of JNK has been found in a variety of cancers including non-small cell lung carcinomas, gliomas, and mantle cell lymphoma. In vitro studies show that constitutive activation of JNK induces a transformed phenotype in fibroblasts and enhances tumorigenicity in a variety of cell lines. Interestingly, a subset of JNK isoforms was recently found to autoactivate rendering the proteins constitutively active. These constitutively active JNK proteins were found to play a pivotal role in activating transcription factors that increase cellular growth and tumor formation in mice. In this chapter, we describe techniques and methods that have been successfully used to study the three components of JNK activation. Use of these techniques may lead to a better understanding of the components of JNK pathways and how JNK is activated in cancer cells.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036249      PMCID: PMC4079000          DOI: 10.1016/B978-0-12-381298-8.00026-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  45 in total

Review 1.  MAP kinases.

Authors:  Z Chen; T B Gibson; F Robinson; L Silvestro; G Pearson; B Xu; A Wright; C Vanderbilt; M H Cobb
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

2.  Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype.

Authors:  Ulrike E E Rennefahrt; Bertram Illert; Eugen Kerkhoff; Jakob Troppmair; Ulf R Rapp
Journal:  J Biol Chem       Date:  2002-05-30       Impact factor: 5.157

3.  Oncogene at last--c-Jun promotes liver cancer in mice.

Authors:  Shin Maeda; Michael Karin
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

4.  The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.

Authors:  Hengning Ke; Rebecca Harris; Jonathan L Coloff; Jane Y Jin; Benjamin Leshin; Paula Miliani de Marval; Shiying Tao; Jeffrey C Rathmell; Russell P Hall; Jennifer Y Zhang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

Review 5.  Mitogen-activated protein kinase kinase 4 (MKK4).

Authors:  A Cuenda
Journal:  Int J Biochem Cell Biol       Date:  2000-06       Impact factor: 5.085

6.  Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes.

Authors:  David Holzberg; C Graham Knight; Oliver Dittrich-Breiholz; Heike Schneider; Anneke Dörrie; Elke Hoffmann; Klaus Resch; Michael Kracht
Journal:  J Biol Chem       Date:  2003-06-27       Impact factor: 5.157

7.  C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma.

Authors:  Yong-Min Yang; Frédéric Bost; Wilfried Charbono; Nicholas Dean; Robert McKay; Johng S Rhim; Chantal Depatie; Dan Mercola
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

8.  The specificities of protein kinase inhibitors: an update.

Authors:  Jenny Bain; Hilary McLauchlan; Matthew Elliott; Philip Cohen
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

9.  Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs.

Authors:  Makoto Ishii; Yukio Suzuki; Kei Takeshita; Naoki Miyao; Hiroyasu Kudo; Rika Hiraoka; Kazumi Nishio; Nagato Sato; Katsuhiko Naoki; Takuya Aoki; Kazuhiro Yamaguchi
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

10.  Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors.

Authors:  Hiromasa Tsuiki; Mehdi Tnani; Isamu Okamoto; Lawrence C Kenyon; David R Emlet; Marina Holgado-Madruga; Irene S Lanham; Christopher J Joynes; Kim T Vo; Albert J Wong
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

View more
  3 in total

1.  Novel link between prostaglandin E2 (PGE2) and cholinergic signaling in lung cancer: The role of c-Jun in PGE2-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferation.

Authors:  XiaoRong Zhong; Yu Fan; Jeffrey D Ritzenthaler; WenJing Zhang; Ke Wang; QingHua Zhou; Jesse Roman
Journal:  Thorac Cancer       Date:  2015-01-14       Impact factor: 3.500

2.  Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.

Authors:  R T Nitta; S Gholamin; A H Feroze; M Agarwal; S H Cheshier; S S Mitra; G Li
Journal:  Oncogene       Date:  2014-09-22       Impact factor: 9.867

3.  A Novel PAK1-Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation.

Authors:  Adrian Frick; Vineeta Khare; Kristine Jimenez; Kyle Dammann; Michaela Lang; Anita Krnjic; Christina Gmainer; Maximilian Baumgartner; Ildiko Mesteri; Christoph Gasche
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.